« Previous | Next » | All Messages |  MGEN Message Board Home | recommend post |  Ignore Poster

MGEN News Med Gen Revenues on the Rise

BOCA RATON, Fla.--(BUSINESS WIRE)--Med Gen Inc. (OTCBB:MGEN), manufacturers of nationally branded OTC healthier life products, announced a substantial increase in revenues for the first half of January.

In discussions with Analysts that follow Med Gen, Paul Kravitz, Chairman/CEO discussed the Med Gen turnaround, prompting a mid-month national release of the company’s revenue. Mr. Kravitz said, “in the month of January thru January 22 2007, the company recorded revenue of $277,000, a 6,000% increase over same month revenue in 2006. This increase follows the reported record revenues reported for November and further validates the year-long marketing efforts that management has put in place. The company’s management project substantial improvement in revenues for its second [March] quarter.”

The company also reported that its newest UnDiet® TV commercial will have a medical endorsement and will air in early February. It will become the TV commercial platform for several new products the company is readying for launch.

About Med Gen Inc.

Med Gen Inc., in business since 1996, manufactures and markets specialty products using its proprietary delivery system Spray’s the Way (“STW”). It is best known for producing the world’s first patented liquid spray snoring relief formula, Snorenz®. Since its existence, Med Gen has continued to develop its STW technology, introducing Good Nights Sleep® and the UnDiet® system into its family of brands. While STW technology is mainly used, the company also produces other products that deal with common health issues using other delivery systems. The company markets its products to distributors, major chain and drug stores, direct sales via the company web site and direct to consumer television, radio and print advertising. The company also distributes its brands internationally under various private labels or existing names.

Med Gen Inc. is a fully reporting company whose stock trades on the OTCBB under the symbol “MGEN”. For information contact Investor Relations, Paul Kravitz, CEO - 561-750-1100 or www.medgen.com.

This Press Release contains or incorporates by reference “forward looking statements" including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words “believes”, “suggests”, “anticipates”, “plans”, “expects”, and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward looking statements.